Wellington Management Group Llp - Dec 31, 2024 SCHEDULE 13G/A Report for Crinetics Pharmaceuticals, Inc. Common Stock (CRNX)

Filing Manager
WELLINGTON MANAGEMENT GROUP LLP
Reporting Manager
Wellington Management Group LLP
Security
Crinetics Pharmaceuticals, Inc. Common Stock
Symbol
CRNX
Shares outstanding
92.7M shares
Disclosed Ownership
6.95M shares
Ownership
7.5%
Form type
SCHEDULE 13G/A
Date filed
2/10/2025, 10:25 AM
Date of event
Dec 31, 2024
Next filing
Aug 12, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Wellington Management Group LLP 7.5% 6.95M 0 6.14M Taisia Lowe Regulatory Analyst
Wellington Group Holdings LLP 7.5% 6.95M 0 6.14M Taisia Lowe Regulatory Analyst
Wellington Investment Advisors Holdings LLP 7.5% 6.95M 0 6.14M Taisia Lowe Regulatory Analyst
Wellington Management Company LLP 7.1% 6.95M 0 6.08M Taisia Lowe Regulatory Analyst